We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01588431
Recruitment Status : Active, not recruiting
First Posted : May 1, 2012
Last Update Posted : January 9, 2017
Sponsor:
Information provided by (Responsible Party):
Anand B. Karnad, The University of Texas Health Science Center at San Antonio

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : March 2022